ABBV: EU Approves MAVIRET
AbbVie's MAVIRET is approved by the European Commission for people with acute Hepatitis C Virus infection
ABBV - AbbVie Announces European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus Infection